Pathogenicity of NUSAP1 Variants Is Defined by NMD ‐Escape: Evidence From Two Novel Cases and Systematic Population‐Based Variant Analysis
Clinical Genetics · 2026-12 · 110 (6) · 768-774
DOI: 10.1111/cge.70244 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Genetics, online erschienen am 07.09.2026. Verfasst von Maureen Jacob und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, School of Medicine and Health, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Developmental Disabilities, Microcephaly, Microtubule-Associated Proteins, Nonsense Mediated mRNA Decay. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung, Technical University of Munich-Institute for Advanced Study, Hertie Foundation.
Abstract (Originalsprache)
Protein‐truncating variants in the 3′ region of a transcript, evading mRNA degradation and giving rise to aberrant truncated proteins, are an underrecognized cause in Mendelian diseases. Here, we report two individuals with heterozygous de novo nonsense variants in the penultimate and last exon of NUSAP1 , both presenting with early‐onset refractory epilepsy, global developmental delay, congenital microcephaly, and a recognizable facial gestalt. RNA sequencing performed in one individual did not show a reduction in expression, compatible with escape of aberrant transcripts from nonsense mediated mRNA decay (NMD). We systematically analyzed gnomAD population data to delineate a critical region at the 3′ region of NUSAP1 , where nonsense variants introduce a premature termination codon and escape NMD. Such variants are absent from healthy controls, while frameshift variants producing C‐terminal elongations appear tolerated. This position‐dependent model provides guidance for diagnostic variant interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Genetics, School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Medical Genetics Unit, Department of Mother and Child and Department of Medical Science, Ferrara University Hospital and Ferrara University, Ferrara, Italy.
- Laboratory of Medical Genetics, Papa Giovanni XXIII Hospital, Bergamo, Italy.
- Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
- Department of Medical Sciences, Pediatric Section, University Hospital of Ferrara, Ferrara, Italy.
- Institute for Advanced Study, Technical University of Munich, Garching, Germany.
ORCID-Profile: Maureen Jacob, Susann Badmann, Stefania Bigoni, Maria Iascone, Robert Kopajtich, Holger Prokisch, Michael Zech, Elisabeth Graf, Matias Wagner, Juliane Winkelmann, Theresa Brunet, Melanie Brugger
Förderung
- Else Kröner-Fresenius-Stiftung
- Technical University of Munich-Institute for Advanced Study
- Hertie Foundation
Zitieren
APA
Jacob, M., Badmann, S., Bigoni, S., Iascone, M., Vivaldi, I., Mayerhanser, K., Kopajtich, R., Prokisch, H., Forest, C., Eck, S., Zech, M., Graf, E., Wagner, M., Winkelmann, J., Brunet, T., & Brugger, M. (2026). Pathogenicity of NUSAP1 Variants Is Defined by NMD ‐Escape: Evidence From Two Novel Cases and Systematic Population‐Based Variant Analysis. Clinical Genetics, 110(6), 768-774. https://doi.org/10.1111/cge.70244
Vancouver
Jacob M, Badmann S, Bigoni S, Iascone M, Vivaldi I, Mayerhanser K, et al. Pathogenicity of NUSAP1 Variants Is Defined by NMD ‐Escape: Evidence From Two Novel Cases and Systematic Population‐Based Variant Analysis. Clinical Genetics. 2026;110(6):768-774. doi:10.1111/cge.70244
BibTeX
@article{Jacob2026,
author = {Jacob, Maureen and Badmann, Susann and Bigoni, Stefania and Iascone, Maria and Vivaldi, Ilaria and Mayerhanser, Katharina and Kopajtich, Robert and Prokisch, Holger and Forest, Cristina and Eck, Sebastian and Zech, Michael and Graf, Elisabeth and Wagner, Matias and Winkelmann, Juliane and Brunet, Theresa and Brugger, Melanie},
title = {Pathogenicity of NUSAP1 Variants Is Defined by NMD ‐Escape: Evidence From Two Novel Cases and Systematic Population‐Based Variant Analysis},
journal = {Clinical Genetics},
year = {2026},
volume = {110},
number = {6},
pages = {768--774},
doi = {10.1111/cge.70244}
}
EUVIMED